Acreage (OTCMKTS:ACRDF) is a vertically integrated cannabis company with licensed operations spanning cultivation, processing and retail across multiple U.S. states. The company focuses on both the adult‐use and medical cannabis markets, producing a range of products that include dried flower, pre‐rolls, concentrates, vape cartridges, edibles and topicals. Acreage’s business model emphasizes end‐to‐end control of the supply chain, from seed genetics and cultivation through manufacturing and distribution to licensed dispensaries.
Since its founding in 2012, Acreage has grown through strategic acquisitions and organic facility build‐outs to establish a presence in states with mature and emerging cannabis markets. The company holds cultivation and processing licenses in key jurisdictions such as California, Florida, Illinois, New York and Massachusetts, among others. Acreage’s retail footprint includes a network of branded dispensaries that feature both in‐store and e-commerce sales channels designed to serve adult‐use consumers and registered medical patients.
In addition to its core cultivation and retail operations, Acreage invests in research and development to advance product innovation, quality assurance and regulatory compliance. The company’s product portfolio is sold under proprietary brand names that cater to a variety of consumer preferences, from high‐potency concentrates to low‐dose edibles and wellness‐oriented topicals. Acreage also collaborates with technology and packaging partners to optimize production efficiency and enhance the consumer experience.
Headquartered in New York City, Acreage is led by a management team with extensive experience in regulated consumer products, life sciences and multi-state retail operations. The company continues to pursue market expansion through additional licensing opportunities and partnerships, positioning itself to capitalize on the evolving legal landscape for cannabis in the United States.
AI Generated. May Contain Errors.
